Alnylam Pharmaceuticals
ALNY
#438
Rank
C$74.03 B
Marketcap
C$560.38
Share price
1.87%
Change (1 day)
61.07%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company